Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population

Y. Fujisawa, K. Yoshino, A. Otsuka, T. Funakoshi, T. Fujimura, Y. Yamamoto, H. Hata, R. Tanaka, K. Yamaguchi, Y. Nonomura, I. Hirai, S. Furudate, H. Okuhira, K. Imafuku, M. Aoki, S. Matsushita

研究成果: Letter

20 引用 (Scopus)
元の言語English
ページ(範囲)213-215
ページ数3
ジャーナルBritish Journal of Dermatology
179
発行部数1
DOI
出版物ステータスPublished - 2018 7

ASJC Scopus subject areas

  • Dermatology

これを引用

Fujisawa, Y., Yoshino, K., Otsuka, A., Funakoshi, T., Fujimura, T., Yamamoto, Y., Hata, H., Tanaka, R., Yamaguchi, K., Nonomura, Y., Hirai, I., Furudate, S., Okuhira, H., Imafuku, K., Aoki, M., & Matsushita, S. (2018). Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population. British Journal of Dermatology, 179(1), 213-215. https://doi.org/10.1111/bjd.16427